KINDLY MD INC. DL-,001 Logo
US49457M1062
A3EGVG
KDLY

KINDLY MD INC. DL-,001

Wczytywanie kursów wyceny...

Prognoza

Nie mamy danych analityków dla tej spółki.


  • Nakamoto keeps chief medical officer after reverse merger with KindlyMD

    Nakamoto retained a Chief Medical Officer because it merged with healthcare provider KindlyMD and must maintain an operating healthcare arm to meet Nasdaq listing rules and avoid shell-company status. The legacy medical business supplies most of Nakamoto’s modest recurring revenue while the crypto treasury side faces scrutiny after a reported $238 million net loss, roughly $200 million in debt and heavy shareholder dilution from recent acquisitions. Management implemented a 1-for-40 reverse split to regain Nasdaq compliance; upcoming insider lock-up releases and the Q2 filing in August will test whether new revenues justify recent deals. » Więcej na finance.yahoo.com


  • KindlyMD renames itself Nakamoto and pivots business toward Bitcoin

    KindlyMD has officially changed its name to Nakamoto Inc. and is positioning itself going forward as a Bitcoin-focused company, while the healthcare business will continue under the subsidiary Kindly LLC. Shares and warrants will continue to trade on NASDAQ under the tickers NAKA and NAKAW. Nakamoto says it has built a Bitcoin reserve of more than $500 million and has invested in strategic international investments; the company plans to continue disciplined accumulation of its holdings and to build a portfolio of Bitcoin-native companies. » Więcej na de.investing.com


  • KindlyMD announces share buyback program after massive price slump

    KindlyMD approved a share buyback program for its outstanding common shares after the stock lost nearly 98% in six months and is trading close to its 52-week low. Management may make purchases in the market, in privately negotiated transactions and in block trades under Rule 10b-18; the program does not commit to acquiring a fixed number of shares. Despite the buyback plan, the company has high indebtedness and a very low short-term liquidity ratio of 0.13; at the same time KindlyMD secured a loan of USD 203 million to repay a convertible note and appointed new finance chiefs, while B. Riley issued a buy recommendation with a USD 2.00 price target. » Więcej na de.investing.com

Dane finansowe spółki

W ostatnim kwartale KINDLY MD INC. DL-,001 osiągnęła przychody w wysokości 31,43 mln € i zysk netto w wysokości -116,53 mln €
(EUR) czerwiec 2026
YoY
Przychody 31,43 mln 8967,67%
Zysk brutto 18,17 mln 5241,81%
Zysk netto -116,53 mln 5590,36%
EBITDA -99,15 mln 4855,53%

Dane fundamentalne

Wskaźnik Wartość
Kapitalizacja rynkowa
58,95 mln €
Liczba akcji
6,02 mln
Maksimum/minimum z 52 tygodni
30,12 € - 0,56 €
Dywidendy Nie
Beta
-0,90
C/Z (PE Ratio)
-0,22
PEG (PEG Ratio)
0,01
C/WK (PB Ratio)
0,66
C/S (PS Ratio)
3,44

Profil spółki

Nazwa
KINDLY MD INC. DL-,001
CEO
Timothy Pickett
Pracownicy 23

Symbole giełdowe

Giełda Symbol
NASDAQ
KDLY
🍪

Parqet  używa plików cookie. Dowiedz się więcej